Year-end report 2010: Continued stable profit development

Year-end report 2010: Continued stable profit development

FOURTH QUARTER 2010

  · Revenues increased by 17 percent to SEK 177.6 million (151.2)
  · The operating result amounted to SEK 12.5 million (-2.9)The result
before tax amounted to SEK 12.8 million (-5.9)
  · The result after tax amounted to SEK 12.6 million (-8.5)
  · The result per share amounted to SEK 0.13 (-0.19)
  · Organic growth of 10 percent
  · Acquisition of Stockholm Gastro Center

WHOLE YEAR 2010

  · Revenues increased by 16 percent to SEK 585.5 million (503.3)
  · The operating result amounted to SEK 28.4 million (-7.2)
  · The result before tax amounted to SEK 29.3 million (-11.2)
  · The result after tax amounted to SEK 20.1 million (-18.4)
  · The result per share amounted to SEK 0.15 (-0.45)
  · Organic growth of 12 percent

THE CEO'S COMMENTS
The fourth quarter of 2010 was characterised by continued good
development of volumes and profitability for the majority of our
clinics, which resulted in a positive result for the Group for the whole
year, well in line with our expectations.

Particularly pleasing is the progress made within the bariatric area,
above all for the Swedish clinics. The Swedish spine and orthopaedic
clinics have also had strong demand and further increased their capacity
utilisation. The Swedish dental clinics note weaker demand for complex
specialist treatments, probably a consequence of the less favourable
public remuneration conditions. However, we are maintaining volumes by
taking market shares at a slightly lower margin. Our arrhythmia clinic
has completed its first full year in business. The clinic is profitable
and is already the ablation centre that performs the most fibrillation
ablations in Sweden.

The prospects for our two newly started Danish bariatric clinics have
deteriorated after notice was given by the Danish National Board of
Health of a large reduction in the public financing of obesity surgery.
This will affect demand negatively during 2011 and probably lead to a
consolidation among existing clinics in the market. We have also
observed continued insufficient allocation of public funds for obesity
surgery in the Czech Republic.

To sum up, we have shown in 2010 that the underlying good profitability
in our clinics together with good cost control regarding central costs
and investments have meant a breakthrough for the development of the
Group's profitability.

23 February 2011
Gothenburg
Global Health Partner AB (publ)

The Board

Queries should be addressed to:
Per Båtelson, CEO, phone  +46-705 95 57 00
Tobias Linebäck, CFO, phone  +46-708 55 37 19
Anna Ahlberg, IR, phone  +46-708 55 38 35